Syngene International Ltd
company logo

Syngene International Ltd

Pharmaceuticals
Large Cap

-

- (0%)


Syngene International Ltd Performance

-

-

-

-


-

-

-

-

-

Syngene International Ltd Fundamentals

30,182.22Cr

57.94

7.09

0.17

12.94

0.17%

105.79

i buttonClick here to know more about Fundamentals

Syngene International Ltd F&O

Syngene International Ltd Option Chainright-arrow

Syngene International Ltd Financials

Syngene International Ltd Financialsright-arrow

Syngene International Ltd Shareholding Pattern

Syngene International Ltd Delivery and Volume

About Syngene International Ltd

Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors. Headquartered in India, the operations are driven by its highly qualifie

Jonathan Hunt

1993

SYNGENE

NameDesignation
Kiran Mazumdar ShawChairperson
Catherine Patricia RosenbergNon Executive Director
Paul Frederick BlackburnIndependent Director
Vijay KuchrooIndependent Director
Jonathan HuntManaging Director & CEO
Vinita BaliLead Independent Director
Priyadarshnini MahapatraCompany Sec. & Compli. Officer
Sharmila KarveIndependent Director
Kush ParmarIndependent Director
SIBAJI BISWASExecutive Director & CFO
Nilanjan RoyIndependent Director
Manja BoermanIndependent Director
News and Events...

Similar Stocks

What's Trending

Syngene International Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Syngene International Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Syngene International Ltd's share price is ₹750.1 as of 2024-07-22.
Syngene International Ltd's P/E ratio is 57.94 times as of 2024-07-22.
Syngene International Ltd's most recent financial reports indicate a price-to-book ratio of 7.09, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Syngene International Ltd's market capitalization is ₹30182.22 Cr as on 2024-07-22.
The current financial records of Syngene International Ltd show a 11.95% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Syngene International Ltd's most recent financial filings, the company has a total asset value of ₹1537.6, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Syngene International Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Syngene International Ltd's 52-week high and low as of 2024-07-22 are ₹765 and ₹740.05, respectively.